Sustainability & Climate

LuminArx and SkyWorks have launched SkyLight, a $1 billion lending platform offering secured debt to a capital-hungry global aviation market.

AEKE's new K1 smart gym combines an AI personal trainer with a disruptive one-time purchase model, aiming to shake up the subscription-heavy fitness market.

Anthology's restructuring concludes, creating a debt-free Blackboard and selling major assets to rivals Ellucian and Encoura in a major EdTech shake-up.

Following a major corporate overhaul, Barnes Aerospace appoints an industry veteran from PCC and Rolls-Royce to accelerate its expansion in aeroengines.

VRIC 2026 gathers global experts to navigate a market reshaped by AI, de-dollarization, and a critical minerals crunch. Is a new super-cycle here?

Amid rising fears of 'forever chemicals' and microplastics, a new filter brings lab-grade technology to your kitchen, promising a safer sip from the tap.

A legislative setback blocks year-round E15 sales, sparking outrage from farmers facing an economic crisis and exposing a deep political divide in Washington.

Stran & Company secures a three-year extension with a top running nonprofit, highlighting the critical logistics and strategy behind marathon merchandise.

A new Canadian patent for a metformin-based eye drop could revolutionize treatment for degenerative eye diseases in both humans and their canine companions.

Insilico Medicine's AI-powered drug ISM8969, a brain-penetrant inhibitor, has been cleared by the FDA for clinical trials in Parkinson's disease.

Privo Technologies reports its PRV211 patch was well-tolerated in a key trial, offering a new, localized approach to preventing oral cancer recurrence.

The sale of a Vacaville assisted living facility highlights a booming investment market fueled by demographics, but raises questions about resident care.

With strong Q1 momentum, Standex faces a complex market. Its upcoming Q2 results will offer key insights into global manufacturing and corporate strategy.

White Cap's latest acquisition of VoidForm Products signals a major push into specialized concrete protection, highlighting key trends in market consolidation.

With a 20% revenue jump and explosive profit growth, Financial Gravity's Q1 results signal its strategy to democratize family office services is paying off.

A major clinical trial setback for a promising liver disease drug leaves patients waiting and puts Bausch Health's future strategy under scrutiny.

Acrivon Therapeutics to unveil pivotal data showing high response rates for its targeted drug ACR-368 in an aggressive endometrial cancer subtype.

Featuring the F-35A's debut and China's C919, the 2026 airshow highlights cutting-edge military tech and the shifting commercial aviation landscape.

With a major new investment, a Canadian startup is scaling its recycling tech to break dependency on China for critical minerals fueling AI, defense, and EVs.

A single patient with a debilitating eye pain condition gains access to an investigational therapy, offering hope where no approved treatments exist.